Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

• Status: Recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loma Linda University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients undergoing urologic surgery.

Exclusion Criteria:

• Pregnant and/or nursing mothers.

• Allergy to bupivacaine.

• History of drug/alcohol abuse.

• Severe cardiovascular, hepatic, renal disease or neurological impairment.